Raye Z. Litten

2.9k citations

26 papers · 2.1k indexed · 1 hit paper · h-index 20

Epidemiology top 2%
Pathology and Forensic Medicine top 2%
General Health Professions top 5%
Clinical Psychology top 5%
Cardiology and Cardiovascular Medicine top 10%

Co-authors: John P. Allen Joanne B. Fertig Thomas F. Babor Raymond F. Anton Norman R. Alpert Henry R. Kranzler Daniel E. Falk Katie Witkiewitz
Topics: Substance Abuse Treatment and Outcomes (15 papers)Alcohol Consumption and Health Effects (14 papers)Muscle Physiology and Disorders (4 papers)
Cited by: Pathology and Forensic Medicine Epidemiology Applied Psychology
Journals: Circulation Research The American Journal of Cardiology American Journal of Physiology-Heart and Circulatory Physiology
Partner nations: United States Germany United Kingdom

In The Last Decade

Raye Z. Litten

26 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Review of Research on the Alcohol Use Disorders Identification Test (AUDIT)

1997 768 citations John P. Allen, Raye Z. Litten et al. Alcoholism Clinical and Experimental Research profile →

Peers

Countries citing papers authored by Raye Z. Litten

Since Specialization

Citations

This map shows the geographic impact of Raye Z. Litten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raye Z. Litten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raye Z. Litten more than expected).

Fields of papers citing papers by Raye Z. Litten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raye Z. Litten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raye Z. Litten. The network helps show where Raye Z. Litten may publish in the future.

Co-authorship network of co-authors of Raye Z. Litten

This figure shows the co-authorship network connecting the top 25 collaborators of Raye Z. Litten. A scholar is included among the top collaborators of Raye Z. Litten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raye Z. Litten. Raye Z. Litten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials in the United States and United Kingdom 2020 ·Addiction ·Katie Witkiewitz,Nick Heather,Daniel E. Falk,Raye Z. Litten,Deborah S. Hasin,Henry R. Kranzler,Karl Mann,Stephanie S. O’Malley,Raymond F. Anton	51
2	Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population 2019 ·Drug and Alcohol Dependence ·Justin Knox,Jennifer Scodes,Melanie M. Wall,Katie Witkiewitz,Henry R. Kranzler,Daniel E. Falk,Raye Z. Litten,Karl Mann,Stephanie S. O’Malley,Raymond F. Anton,Deborah S. Hasin	40
3	Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial 2019 ·Alcoholism Clinical and Experimental Research ·Katie Witkiewitz,Daniel E. Falk,Raye Z. Litten,Deborah S. Hasin,Henry R. Kranzler,Karl Mann,Stephanie S. O’Malley,Raymond F. Anton	43
4	Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT‐C Scores: Prospective 3‐Year Follow‐Up Results in the U.S. General Population 2018 ·Alcoholism Clinical and Experimental Research ·Justin Knox,Melanie M. Wall,Katie Witkiewitz,Henry R. Kranzler,Daniel E. Falk,Raye Z. Litten,Karl Mann,Stephanie S. O’Malley,Jennifer Scodes,Raymond F. Anton,Deborah S. Hasin	51
5	Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE Study 2017 ·Alcoholism Clinical and Experimental Research ·Katie Witkiewitz,Adam D. Wilson,Matthew R. Pearson,Kevin A. Hallgren,Daniel E. Falk,Raye Z. Litten,Henry R. Kranzler,Karl Mann,Deborah S. Hasin,Stephanie S. O’Malley,Raymond F. Anton	26
6	Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels 2016 ·Alcoholism Clinical and Experimental Research ·Katie Witkiewitz,Kevin A. Hallgren,Henry R. Kranzler,Karl Mann,Deborah S. Hasin,Daniel E. Falk,Raye Z. Litten,Stephanie S. O’Malley,Raymond F. Anton	110
7	Missing Data in Alcohol Clinical Trials with Binary Outcomes 2016 ·Alcoholism Clinical and Experimental Research ·Kevin A. Hallgren,Katie Witkiewitz,Henry R. Kranzler,Daniel E. Falk,Raye Z. Litten,Stephanie S. O’Malley,Raymond F. Anton	28
8	Methods to Analyze Treatment Effects in the Presence of Missing Data for a Continuous Heavy Drinking Outcome Measure When Participants Drop Out from Treatment in Alcohol Clinical Trials 2014 ·Alcoholism Clinical and Experimental Research ·Katie Witkiewitz,Daniel E. Falk,Henry R. Kranzler,Raye Z. Litten,Kevin A. Hallgren,Stephanie S. O’Malley,Raymond F. Anton	50
9	Introduction: National Institute on Alcohol Abuse and Alcoholism Workshop on Treatment Research Priorities and Health Disparities 2003 ·Alcoholism Clinical and Experimental Research ·(unknown),Cherry Lowman,Raye Z. Litten,Margaret E. Mattson	12
10	The Role of Biomarkers in Alcoholism Medication Trials 2001 ·Alcoholism Clinical and Experimental Research ·John P. Allen,Raye Z. Litten,(unknown),Pekka Sillanaukee	2
11	Pharmacologic treatment of alcoholics with collateral depression: issues and future directions. 1998 ·PubMed ·Raye Z. Litten,J.P. Allen	10
12	A Review of Research on the Alcohol Use Disorders Identification Test (AUDIT)breakdown → 1997 ·Alcoholism Clinical and Experimental Research ·John P. Allen,Raye Z. Litten,Joanne B. Fertig,Thomas F. Babor	768
13	Disulfiram (Antabuse) Contracts in Treatment of Alcoholism 1995 ·PsycEXTRA Dataset ·Timothy J. O’Farrell,John P. Allen,Raye Z. Litten	26
14	Carbohydrate‐Deficient Transferrin as a Measure of Immoderate Drinking: Remaining Issues 1994 ·Alcoholism Clinical and Experimental Research ·John P. Allen,Raye Z. Litten,Raymond F. Anton,Gerald M. Cross	154
15	Techniques to Enhance Compliance with Disulfiram 1992 ·Alcoholism Clinical and Experimental Research ·John P. Allen,Raye Z. Litten	48
16	Pharmacotherapies for Alcoholism: Promising Agents and Clinical Issues 1991 ·Alcoholism Clinical and Experimental Research ·Raye Z. Litten,John P. Allen	85
17	Alterations in rat cardiac myosin isozymes induced by whole-body irradiation are prevented by 3,5,3′-l-triiodothyronine 1990 ·Metabolism ·Raye Z. Litten,Henry G. Fein,(unknown),Thomas L. Walden,Robert C. Smallridge	4
18	Alteration of cardiac myosin isozymes after whole-body irradiation 1989 ·British Journal of Radiology ·Raye Z. Litten,Thomas L. Walden,(unknown),R Nagai	1
19	Altered myosin isozyme patterns from pressure-overloaded and thyrotoxic hypertrophied rabbit hearts. 1982 ·Circulation Research ·Raye Z. Litten,Barbara J. Martin,R B Low,Norman R. Alpert	167
20	Phosphorylation and adenosine triphosphatase activity of myofibrils from thyrotoxic rabbit hearts. 1981 ·Circulation Research ·Raye Z. Litten,Barbara J. Martin,(unknown),Norman R. Alpert,R. John Solaro	26

About Raye Z. Litten

Raye Z. Litten is a scholar working on Pathology and Forensic Medicine, Epidemiology and Toxicology, having authored 26 papers that have together received 2.1k indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (15 papers), Alcohol Consumption and Health Effects (14 papers) and Muscle Physiology and Disorders (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (724 citations), Epidemiology (1.1k citations) and Applied Psychology (154 citations). Raye Z. Litten has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include John P. Allen, Joanne B. Fertig, Thomas F. Babor, Raymond F. Anton, Norman R. Alpert, John P. Allen, Henry R. Kranzler, Daniel E. Falk, Katie Witkiewitz and R B Low. Their work appears in journals such as Circulation Research, The American Journal of Cardiology and American Journal of Physiology-Heart and Circulatory Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact